AFAP1-AS1 regulates lung cancer proliferation, migration, and invasion through the competitive upregulation of RRM2 to inhibit miR-139-5p, IRF7, and RIG-I-like receptor signaling pathways, or epigenetic inhibition of p21 expression [39–41]. Here, IRF7 is linked to lung carcinoma.